Morroniside ameliorates sevoflurane anesthesia-induced cognitive dysfunction in aged mice through modulating the

Jianxing Chen1, Bo Peng2, Wenqian Lin3

  • 1Department of Anesthesiology, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Department of Anesthesiology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China; Anesthesiology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.

Biomolecules & Biomedicine
|December 13, 2024
PubMed

Insights

Morroniside (Mor) improves cognitive impairment in aged mice by blocking the TLR4/NF-κB pathway. This action reduces neuroinflammation and hippocampal damage caused by sevoflurane (Sev) anesthesia.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Biochemistry

Background:

  • Prolonged sevoflurane (Sev) anesthesia can lead to postoperative cognitive dysfunction (POCD) in aged individuals.
  • Morroniside (Mor), a compound from Cornus officinalis, exhibits anti-inflammatory, neuroprotective, and antioxidant effects.
  • Understanding Mor's mechanism against Sev-induced cognitive impairment is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the protective mechanism of Mor against sevoflurane-induced cognitive dysfunction in aged mice.
  • To elucidate Mor's effects on neuroinflammation, neuronal apoptosis, and microglial activation in the hippocampus.
  • To determine Mor's interaction with the TLR4/NF-κB signaling pathway.

Main Methods:

  • Sevoflurane-induced cognitive dysfunction model in aged mice.
  • Behavioral analysis using the water maze test.
  • Histopathological examination (HE, Nissl, TUNEL staining) of hippocampal tissue.
  • ELISA and qRT-PCR for inflammatory factors and microglial polarization.
  • Molecular docking, Western blot, and immunofluorescence for pathway analysis.

Main Results:

  • Sevoflurane significantly impaired learning and memory, which Mor dose-dependently improved.
  • Mor reduced hippocampal neuroinflammation, neuronal apoptosis, and modulated microglial polarization towards M2 phenotype.
  • Mor demonstrated binding affinity with TLR4, reduced its expression, and inhibited the TLR4/NF-κB pathway activation.
  • The TLR4 agonist CRX-527 counteracted Mor's protective effects, confirming pathway involvement.

Conclusions:

  • Morroniside effectively ameliorates sevoflurane-induced cognitive impairment in aged mice.
  • The protective effects are mediated by inhibiting the TLR4/NF-κB pathway, reducing neuroinflammation and apoptosis.
  • Mor modulates microglial activation and protects hippocampal tissue, offering a potential therapeutic strategy for POCD.

Related Concept Videos